News Articles for Rohan Hockings

PYC launches major $653m raise

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth biotech PYC Therapeutics will go to market seeking $653 million to advance four of its treatments through early trial stages and towards their first transaction.The Nedlands-based ASX-list

Coleman appointed PYC chair

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

PYC Therapeutics has announced that Peter Coleman has been appointed non-executive chair, effective from the end of its annual general meeting on November 18.

Board moves September 24, 2025

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Today's board moves wrap includes Michael Rosenblatt, Jason Haddock, Mark Okeby, Rob Tyson, Oliver Stewart, Charles Mac, David Dikken, Douglas MacLennan, Alexius Chan, Ian Constable, Rohan Hockings, Nick Woolrych, Ronnie Beevor, Gaurav Gupta, Greg Jason, Lisa Breen, Tommy Logtenberg, Paul Berend, Zane Lewis, Joydeep Dasgupta, Brendan Shalders, Anthony Greenaway, Kevin Lynn and Clinton Moxham.

Appointments September 26, 2025

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

This week's business appointments include Rohan Hockings, Karen Priest, Janelle Marr, and more.

Hockings reappointed PYC MD

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based biotech company PYC Therapeutics has reappointed Rohan Hockings as its managing director, five days after he announced his resignation.

PYC enters trading halt

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

PYC Therapeutics has ducked into a trading halt, just two days after it was announced that its managing director had resigned.

Hockings resigns as PYC boss

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based biotech company PYC Therapeutics is on the hunt for a full-time managing director, following the resignation of Dr Rohan Hockings.

PYC looks to build $200m coffers

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Nedlands-based biotech company PYC Therapeutics is rattling the tin for up to $146 million to fund the progression of four novel drug candidates.Company chair and largest shareholder Alan Tribe

PYC Therapeutics hit FDA milestone

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth biotech company PYC Therapeutics has hit a major milestone in the development of a first-in-class drug to treat a rare eye disease, recently receiving orphan drug designation from the US FDA.

PYC taps investors for $75m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

PYC Therapeutics is rattling the tin for up to $74.6 million to fund the progress of its medical drug trials, including for blinding eye and polycystic kidney diseases.

Perth biotech company raises $30m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Nedlands-based biotechnology company PYC Therapeutics has raised $30 million to progress its series of drug trials.

Exal Group buys $44m Freo warehouse

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Property developer Exal Group has bought a 31,100 square metre lot from a Chinese real estate group, as it progresses its plans for its project worth more than $500 million at the site.

Hockings hopes for blindness drug

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

40under40: The journey from an idea to an approved medication is as difficult as putting a person on the moon, Rohan Hockings says.

Riches takes top spot at 40under40 awards

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

GenusPlus Group managing director David Riches was named First Amongst Equals at the 2022 40under40 Awards, ahead of a diverse cohort of Western Australia's young business leaders.

Exal Group with $500m North Freo hub

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The developer is seeking community input before submitting its plans for the vacant site.

Vision Pharma wins top innovator award

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A company targeting treatment of blindness was announced as the WA Innovator of the Year on Wednesday night.

Finalists named in WA Innovator of the Year awards

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Four companies including VeinTech and Vision Pharma have been selected as finalists in the Great for the State category at the Innovator of the Year Awards.

Tribe’s experience adding value to PYC Therapeutics

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The rising fortunes of biotech company PYC Therapeutics have bolstered the wealth of its major shareholders, most notably chairman Alan Tribe.

PYC Therapeutics seeks $55m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Biotech company PYC Therapeutics has sought funding for its lead drug development program that aims to treat childhood blindness.

Board Moves August 19, 2020

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Richard Monti, Kristie Young, Bryn Hardcastle, Rohan Hockings, Douglas Huey, Dale Schultz, Paul Summers, and Louie Simens.

Board Moves February 12, 2020

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Dampier Gold has appointed Gavin Solomon as special advisor to the board of directors.

Phylogica partners with Lions Eye Institute

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Phylogica has announced a commercial collaboration with Lions Eye Institute trading under the name Vision Pharma, bringing the biotechnology company a step closer to commercialising its drug delivery technology.

Phylogica shares stabilise after big rally

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth biotech Phylogica today announced positive test results from its drug delivery technology, but the news was not enough to sustain a rally in the company's shares, which have risen 33 per cent over the past week.

Board Moves November 30, 2018

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Andrew Haslam and Martin Bryant have resigned as non-executive directors of BCI Minerals.

Phylogica in $9.1m recapitalisation

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Shares in biomedical technology business Phylogica were up 13 per cent today after the company announced it had completed a $9.1 million recapitalisation.

No hard cell for Phylogica

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Phylogica has a new chief executive who is determined to bring the Perth biotech's commercialisation strategy to fruition.

Phylogica appoints new chair, CEO

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Former IKEA franchise owner Alan Tribe has taken charge at local biotech firm Phylogica, lifting his stake to 20 per cent and becoming chairman on the same day chief executive Stephanie Unwin was replaced by Rohan Hockings.

Board moves August 13 - August 22 2016

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Malcolm Randall has resigned as chair at MZI Resources, but will remain a non-executive director. Rod Baxter has been appointed chair.